News | May 23, 2011

Treatment Planning Software Maker Sues Over Alleged Patent Infringement

May 23, 2011 - Radiation Therapy treatment planning system developers RaySearch Laboratories AB and Prowess Inc. are involved in patent infringmenrt litigation. Prowess recently filed a complaint against RaySearch for U.S. patent infringement in a court in Baltimore, Md.

RaySearch said the two companies had been in discussions over the issue, but they were fruitless and Prowess moved ahead with the litigation.

The patent concerns direct optimization of machine parameters in radiation treatment planning and was issued in 2007 by the U.S. patent authority USPTO. Prowess has said that it holds an exclusive license to this patent, which is owned by the University of Maryland. RaySearch has been involved in discussions with Prowess where RaySearch has stated its position that there is no infringement and in addition, that the patent could be invalidated since there is prior art in older publications describing the same concept.

“This concerns a method that we had independently developed and implemented at the Karolinska Institute already in the ‘90s. In addition, both we and others had published articles about the method before this patent application was filed. We do believe that we have a strong case and therefore consider our chances of winning this dispute to be good,” said Johan Löf, CEO of RaySearch.

Prowess Inc. is an international radiation cancer treatment planning software developer, using Windows-based systems.

RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA Dosimetry, Varian, TomoTherapy and Siemens. To date, 15 products have been launched through partners and RaySearch’s software is used at some 1,800 clinics in more than 30 countries.

For more information: www.raysearchlabs.com, www.prowess.com

Related Content

ASTRO and ASCO Launch New Cancer Care Quality Registry
News | Radiation Therapy | January 22, 2018
January 22, 2018 — A registry that tracks the quality of medical care provided to patients receiving cancer treatment
First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
Overlay Init